VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93 | +138.5% | 15,000 | +36.4% | 0.00% | – |
| Q2 2023 | $39 | -70.0% | 11,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $130 | -99.4% | 11,000 | -17.9% | 0.00% | – |
| Q3 2022 | $21,000 | -87.6% | 13,400 | -33.0% | 0.00% | -100.0% |
| Q2 2022 | $170,000 | -52.5% | 20,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $358,000 | -29.8% | 20,000 | -80.0% | 0.00% | 0.0% |
| Q4 2021 | $510,000 | -86.5% | 100,000 | 0.0% | 0.00% | -83.3% |
| Q3 2021 | $3,764,000 | +30.2% | 100,000 | 0.0% | 0.02% | +38.5% |
| Q2 2021 | $2,890,000 | +288900.0% | 100,000 | +557.9% | 0.01% | – |
| Q1 2020 | $1,000 | -99.7% | 15,200 | +26.7% | 0.00% | -100.0% |
| Q4 2016 | $301,000 | +65.4% | 12,000 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $182,000 | -30.8% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $263,000 | -11.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $298,000 | +127.5% | 12,000 | 0.0% | 0.00% | +100.0% |
| Q4 2015 | $131,000 | -39.6% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $217,000 | +52.8% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $142,000 | -26.0% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $192,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 47,200 | $14,871,304 | 0.02% |
| SIMPLEX TRADING, LLC | 62,100 | $19,565 | 0.02% |
| GROUP ONE TRADING, L.P. | 14,300 | $4,505,501 | 0.02% |
| JANE STREET GROUP, LLC | 55,200 | $17,391,864 | 0.01% |
| Allianz Asset Management GmbH | 11,200 | $3,528,784 | 0.01% |
| SG Americas Securities, LLC | 11,000 | $130 | 0.00% |
| JPMORGAN CHASE & CO | 23,200 | $7,310,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |